✨ 994 results found - Searched 22805 records in 10ms.
Disertasi
Efek Pemberian Bromokriptin terhadap Respon Kemoterapi Neoadjuvan Berbasis Antrasiklin pada Kanker Payudara dengan Ekspresi Reseptor Prolaktin, JAK2, GST, Bcl-2, dan ERK-1
2025 | BY Sonar Soni Panigoro - Primariadewi Rustamadji - Chaidir Arif Mochtar - M. Yadi Permana- Effect of Bromocryptin Administration on the response of Anthracycline- Based Neoadjuvant Chemotherapy in Breast Cancer with Expression of Prolactin Receptors, JAK2, GST, BCL-2 AND ERK-1.
- Nomor Panggil D25016fk
Disertasi
Faktor Prediktor Diagnostik Invasi Limfovaskular pada Kanker Endometrium Tipe 1 Kajian Status Instabilitas Mikrosatelit, Distribusi CD8+, dan Ekspresi Programmed Death-Ligand 1
2025 | BY ANDRIJONO - Nur Rahadiani - Nurjati Chairani Siregar - Wiwit Ade Fidiawati- Diagnostic Predictors of Lymphovascular Invasion in Endometrial Cancer Type 1: A Study on Microsatellite Instability Status, CD8+ Distribution, and Programmed Death-Ligand 1 Expression.
- Nomor Panggil D25013fk
Disertasi
Pengembangan Model Probabilitas Respons Akhir Terapi Radiasi Kanker Serviks Stadium Lanjut Menggunakan Parameter Apparent Diffusion Coefficient dan T2 Tumor pada Magnetic Resonance Imaging: Kaitannya Dengan Ekspresi Survivin
2025 | BY Trifonia Pingkan Siregar - Fitriyadi Kusuma - Sawitri Darmiati - Septelia Inawati Wanandi- Development of Probability Model for Final Response to Advanced Stage Cervical Cancer Therapy using Apparent Diffusion Coefficient and T2 Tumour Parameter on Magnetic Resonance Imaging: Associated with Survivin Expression.
- Nomor Panggil D25011fk
Tesis
Prevalens dan Luaran Pasien Kanker Anak dengan COVID-19 Terkonfirmasi yang Dirawat di Rumah Sakit Rujukan COVID-19 - RSCM
2025 | BY Novita Wulansari - MURTI ANDRIASTUTI - Nina Dwi Putri- Prevalence and Outcome of Childhood Cancer Patients with Confirmed COVID-19 Treated at COVID-19 Referral Hospital – RSCM.
- Nomor Panggil T25072fk
Tesis
Eksplorasi Mekanisme Pemberian Ekstrak Jahe Merah (Zingiber officinale) dalam Menghambat Pertumbuhan Sel Kanker Kolorektal Caco-2
2024 | BY Muhammad Alsyifaa Dharmawan - Fadilah - Surya Dwira- Exploration of Red Ginger (Zingiber officinale) Mechanism on Inhibiting the Growth of Caco-2 Colorectal Cancer Cells.
- Nomor Panggil T24621fk
Tesis
Pengaruh Ekspresi Mir-29A dan Mir-31 Terhadap Respons Radiasi pada Pasien Kanker Serviks Stadium Lanjut
2024 | BY Denny Sanjaya - Andi Darma Putra - Aria Kekalih- Effect of Mir-29A and Mir-31 Expression on Radiation Response in Advanced Cervical Cancer Patients.
- Nomor Panggil T24620fk
Tesis
Perbandingan Hasil Temuan Pemeriksaan USG dan Ct Scan pada Kanker Ovarium Stadium Lanjut di Rumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo.
2024 | BY Gatot Purwoto - Dhanasari Vidiawati Sanyoto - Trifonia Pingkan Siregar- Nomor Panggil T24619fk
Tesis
Hubungan Chemotherapy-Induced Nausea and Vomiting Terhadap Kualitas Hidup Pasien Kanker Ovarium yang Mendapatkan Rejimen Kemoterapi Carboplatin-Paclitaxel di Rumah Sakit Umum Pusat Nasional dr. Cipto Mangunkusumo Juni-Oktober 2024
2024 | BY RIZKI AZENDA - Hariyono Winarto - Aria Kekalih- The Relationship Between Chemotherapy-Induced Nausea and Vomiting and the Quality of Life of Ovarian Cancer Patients Receiving Carboplatin-Paclitaxel Chemotherapy Regimen at Dr. Cipto Mangunkusumo National General Hospital (RSCM).
- Nomor Panggil T24618fk
Tesis
Perbedaan Kadar Selenium pada Kanker Ovarium Tipe Epitelial pada Stadium Awal dan Stadium Lanjut
2024 | BY Lubena - Kartiwa Hadi Nuryanto - Endy Cahyono - Nani Cahyani Sudarsono- The Difference of Selenium level in Epithelial Ovarian Cancer between Early and Advanced stages.
- Nomor Panggil T24617fk
Tesis
Kesintasan Pada Kanker Paru Karsinoma Bukan Sel Kecil Jenis Adenokarsinoma Dengan Mutasi Epidermal Growth Factor Receptor Yang Diterapi Dengan Tyrosin Kinase Inhibitor Selama ≥ 18 Bulan Dan Faktor-Faktor Yang Memengaruhinya Di Rumah Sakit Umum Pusat Persahabatan
2024 | BY Vira Weldimira - Sita Laksmi Andarini - Jamal Zaini- Survival in non-small cell carcinoma lung cancer of adenocarcinoma type with epidermal growth factor receptor mutation treated with tyrosine kinase inhibitors for ≥ 18 months and influencing factors at RSUP Persahabatan.
- Nomor Panggil T24614fk